Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Clinical Outcomes of Levosimendan in E-CPR

NCT05730907 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT05730907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05730907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Clinical Outcomes of Levosimendan in E-CPR
Lead sponsor
Hamad Medical Corporation
Phase
Observational
Overall status
Unknown status
Start date
February 20, 2023
Completion date
April 30, 2023
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiogenic shock, extracorporeal membrane oxygenation complication